Elnady Basant, Almalki Abdulaziz, Abdel-Fattah Moataz M, Desouky Dalia El-Sayed, Attar Mohammed
Department of Rheumatology, Rehabilitation and Physical Medicine, Benha University, Benha, Egypt.
Department of Rheumatology, Al Hada Armed Forces Hospital, Al Hada, Saudi Arabia.
Clin Rheumatol. 2021 May;40(5):1827-1834. doi: 10.1007/s10067-020-05473-x. Epub 2020 Oct 23.
The objectives of this study are to assess serum different uric acid levels among systemic lupus erythematosus patients with or without active lupus nephritis in comparison to healthy controls and to study the relation of baseline uric acid levels to the development of new-onset renal damage in lupus nephritis.
This is a case-control study followed by a prospective cohort of systemic lupus erythematosus (SLE) patients. Three groups were included; all were having normal kidney function, 25 SLE patients with recently diagnosed active lupus nephritis (LN), 26 SLE patients without LN, and 38 healthy controls. Serum uric acid (SUA)and serum creatinine were done for all groups; for SLE patients, 24-h protein in the urine, urinalysis, C3, C4 levels, anti-DNA, anti-ENA antibodies, SLE Disease Activity Index (SLEDAI), and SLICC/ACR damage index (SDI) evaluation were also calculated. Follow-up was done with clinical and laboratory assessment including SUA, with SLEDAI and SDI evaluation.
Serum uric acid was significantly higher in SLE patients with active LN than the other two groups (p < 0.05), a cutoff value of serum uric acid associated with lupus nephritis onset was 0.41 mmol/L with a sensitivity of 58% and specificity of 100%, however, C3 and C4 showed very low sensitivity and specificity. During follow-up, all patients with LN with baseline serum uric acid ≥ 0.52 mmol/L were associated with new-onset renal damage within 43 months.
High-serum uric acid levels showed a significant association with lupus nephritis onset and new onset of renal damage. Key Points • Serum uric acid is a cheap, rapid, and popular test available in most of the worldwide laboratories; its higher levels showed a significant association with lupus nephritis onset and new onset of renal damage • The current work is the largest study done on lupus nephritis with strict control to the confound risk factors that are associated with the increase of the uric acid levels; moreover, it is the first study to assess such relation in Saudi population • Uric acid could have a role in the pathogenesis of lupus nephritis patients and consequent renal damage.
本研究的目的是评估有或无活动性狼疮性肾炎的系统性红斑狼疮患者与健康对照者之间血清尿酸水平的差异,并研究基线尿酸水平与狼疮性肾炎新发肾损害发生之间的关系。
这是一项病例对照研究,随后对系统性红斑狼疮(SLE)患者进行前瞻性队列研究。纳入三组;所有患者肾功能均正常,25例近期诊断为活动性狼疮性肾炎(LN)的SLE患者,26例无LN的SLE患者,以及38名健康对照者。对所有组均检测血清尿酸(SUA)和血清肌酐;对于SLE患者,还计算24小时尿蛋白、尿液分析、C3、C4水平、抗DNA、抗ENA抗体、SLE疾病活动指数(SLEDAI)和SLICC/ACR损伤指数(SDI)。通过临床和实验室评估进行随访,包括SUA、SLEDAI和SDI评估。
活动性LN的SLE患者血清尿酸显著高于其他两组(p<0.05),与狼疮性肾炎发病相关的血清尿酸临界值为0.41 mmol/L,敏感性为58%,特异性为100%,然而,C3和C4的敏感性和特异性非常低。在随访期间,所有基线血清尿酸≥0.52 mmol/L的LN患者在43个月内均出现新发肾损害。
高血清尿酸水平与狼疮性肾炎发病和新发肾损害显著相关。要点•血清尿酸是一种在全球大多数实验室都可进行的廉价、快速且常用的检测;其较高水平与狼疮性肾炎发病和新发肾损害显著相关•本研究是对狼疮性肾炎进行的最大规模研究,严格控制了与尿酸水平升高相关的混杂危险因素;此外,这是首次在沙特人群中评估这种关系的研究•尿酸可能在狼疮性肾炎患者的发病机制及随后的肾损害中起作用。